Company Name:Puma Biotechnology Inc
CEO: Alan H. Auerbach

Sector: Healthcare
Industry:Biotechnology

Exchange: Nasdaq Global Select

Country: USA

Description: Puma Biotechnology Inc is a biopharmaceutical company. It is engaged in the acquisition, development and commercialization of products to enhance cancer care. Its drug candidates are PB272 (neratinib, oral), PB272 (neratinib, intravenous), and PB357.


Key numbers

Market Capitalization:361947690
Shares Outstanding: 38961000
Float: 33641849
Next Earning Date:2020-02-26
TTm EPS: -2.4682
TTm Dividend Rate:
200 days moving average:16.97
50 days moving average: 8.07
One day percent Change: 9.42



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,